Drug Profile
Te
Alternative Names: 3-Ethyl-3'-methyl-thiatelluracarbocyanine iodideLatest Information Update: 01 May 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Electron transport complex I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 03 Oct 1996 Preclinical development for Cancer in USA (Unknown route)